![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia
Introduction: Congenital diaphragmatic hernia (CDH) remains a frustating cause of respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN). Although in...
-
Article
Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants
To assess changes associated with nitric oxide (NO) discontinuation in neonates receiving inhalational NO therapy as a treatment for pulmonary hypertension of the neonate (PPHN).
-
Chapter
Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN) is a complex disorder associated with a wide array of cardiopulmonary diseases. PPHN is characterized by marked pulmonary hypertension and altered vasore...